Study 1 — Neuroprotective Effects in a Parkinson’s Model

Type: Preclinical (model organism: Caenorhabditis elegans)

Title: Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Parkinson’s Disease Model (2015).

• What they did: Fed worms a methanolic extract of C. crispus and measured α-synuclein aggregation, dopaminergic neuron survival, movement, and stress-response genes.
• Key findings: Reduced α-synuclein accumulation; protection of dopaminergic neurons under 6-OHDA toxin challenge; improved locomotion; upregulated antioxidant/stress pathways.
• Limitations: Worm model data do not establish efficacy or dosing in humans.

Read the full open-access paper (Marine Drugs, 2015)

Study 2 — Prebiotic Effects in Weaning Rats

Type: Animal study (rats)

Title: Prebiotic effects of diet supplemented with cultivated Chondrus crispus on host immunity, colonic microbiota, and microbial metabolites (2015).

• What they did: Supplemented rat diets with cultivated C. crispus; profiled gut microbiota (16S rRNA) and short-chain fatty acids.
• Key findings: Modulated gut microbial composition and increased beneficial metabolites (SCFAs), suggesting prebiotic potential.
• Limitations: Not a human trial; dose/form may differ from consumer products.

PubMed record  |  Read the full open-access article

Study 3 — Immune Modulation in an Infection Model

Type: Preclinical (worm infection model)

Title: Components of cultivated Chondrus crispus enhance the immune response of C. elegans to Pseudomonas aeruginosa (2013).

• What they did: Tested water extract (CCWE) for effects on innate immune gene expression and bacterial virulence during infection.
• Key findings: Upregulated innate immune genes (≥2×); suppressed bacterial quorum-sensing/virulence genes; ~28% lower worm mortality vs. control.
• Limitations: Findings in C. elegans cannot be assumed in humans.

Read the full open-access paper

Study 4 — Nutritional Value & Antioxidant Capacity

Type: Comparative analysis (cultivated powders; in-vitro bioactivity)

Title: Seaweed Nutritional Value and Bioactive Properties: Insights from Ascophyllum nodosum, Palmaria palmata, and Chondrus crispus (2024).

• What they did: Profiled macro/micronutrients and tested antioxidant & cytotoxic activities of three seaweeds, including C. crispus.
• Key findings: C. crispus showed a robust mineral profile (e.g., calcium, iron, zinc) and measurable in-vitro antioxidant capacity.
• Limitations: In-vitro activity ≠ clinical efficacy; bioavailability and human outcomes were not assessed.

Read the open-access article (Life, 2024)  |  PubMed record

Study 5 — Iodine Content & Safety (Review)

Type: Narrative review (red algae genus Chondrus)

Title: An Update on the Chemical Constituents and Biological Properties of Selected Species of an Underpinned Genus of Red Algae: Chondrus (2024).

• What they report: Chondrus species, including C. crispus, can be significant iodine sources; iodine content and bioavailability vary by species, harvest, and processing.
• Why it matters: Iodine is essential for thyroid function, but excess intake can disrupt it—highlighting the need for moderation and quality sourcing.
• Limitations: Review synthesizes prior studies; does not provide new human clinical trials.

Read the open-access review (Marine Drugs, 2024)  |  PubMed record

Safety Notes & Iodine Guidance

• Iodine content varies: Analyses of Irish moss show variable iodine levels; even small daily amounts can contribute meaningfully to intake in some groups.
• Example: One risk assessment estimated that 4 g/day of dehydrated Irish moss could provide ~25.7% of children’s daily iodine needs (context-specific; not a general dose recommendation).
• Practical advice: Use moderation, buy from tested/transparent suppliers, and consult your clinician if you have thyroid conditions, are pregnant, or use thyroid-active medications.

Sources: Iodine intake risk assessment (2020)  |  Iodine in macroalgae foods & supplements (2021) 

What the Research Does Not Yet Show

• No large, high-quality human clinical trials confirming disease outcomes from sea moss consumption.
• Preclinical and in-vitro findings do not establish efficacy, safety, or dosing in people.
• Bioavailability, long-term safety, and drug-nutrient interactions require further research.

Conclusion

Peer-reviewed studies suggest Chondrus crispus has promising bioactive properties (antioxidant activity, prebiotic effects in animals, immune modulation in model organisms). However, robust human data are limited. We will update this page as high-quality research emerges.

References (Direct Links)

1. Liu J, et al. Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Parkinson’s Disease Model. Marine Drugs. 2015.
   PMC full text  |  PubMed
2. Liu J, et al. Prebiotic effects of diet supplemented with cultivated Chondrus crispus… BMC Complement Altern Med. 2015.
   PMC full text  |  PubMed
3. Liu J, et al. Components of the cultivated red seaweed Chondrus crispus enhance the immune response of C. elegans… 2013.
   PMC full text  |  PubMed
4. Čmiková N, et al. Seaweed Nutritional Value and Bioactive Properties: Insights from A. nodosum, P. palmata, and C. crispus. Life. 2024;14(11):1522.
   Open access  |  PubMed
5. Park SJ, Sharma A, Lee H-J. An Update on the Chemical Constituents and Biological Properties of Selected Species of an Underpinned Genus of Red Algae: Chondrus. Marine Drugs. 2024;22(1):47.
   Open access  |  PubMed
6. Darias-Rosales J, et al. Risk assessment of iodine intake from the consumption of red seaweeds (P. palmata, C. crispus). 2020.
   PubMed
7. Aakre I, et al. Macroalgae foods and supplements as iodine sources—valuable or risk of excess? 2021.
   PMC full text

Experience Sea Moss the Right Way

Rooted in real research and honest craftsmanship, our sea moss is prepared to keep its natural goodness intact while honoring the waters it comes from.
Only clean, simple ingredients — responsibly sourced and handled with care — so you can enjoy sea moss that feels genuine and good for you.

Shop Authentic Sea Moss ↗